...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Do I need to be a member of Pubmed in order to see these reviews? I'm unable to see anything more than a couple sentences outlining the articles.

Thanks 

tada

It was interesting in the prelude to the one where it shows 79 previous articles and publications on epigenetics. That library gets bigger every month so more and more people will have some familiarity.

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply